Publication:

Viral Infection InducesDe NovoLesions of Coronary Allograft Vasculopathy Through a Natural Killer Cell-Dependent Pathway

Loading...
Thumbnail Image

Date

2009

Journal Title

Journal ISSN

Volume Title

Publisher

Wiley-Blackwell
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Graham, J. A., R. A. Wilkinson, T. Hirohashi, C. M. Chase, R. B. Colvin, J. C. Madsen, J. A. Fishman, and P. S. Russell. 2009. “Viral Infection InducesDe NovoLesions of Coronary Allograft Vasculopathy Through a Natural Killer Cell-Dependent Pathway.” American Journal of Transplantation 9 (11) (November): 2479–2484. doi:10.1111/j.1600-6143.2009.02801.x.

Abstract

Viral infections including those due to cytomegalovirus (CMV) have been associated with accelerated cardiac allograft vasculopathy (CAV) in clinical trials and some animal models. Evidence demonstrating a direct causal relationship between such infections and de novo formation of coronary vascular lesions is lacking. Heterotopic murine cardiac transplants were performed in a parental to F1 combination in animals lacking both T- and B-lymphocytes (RAG−/−). Coronary vasculopathy developed almost exclusively in the presence of recipient infection with lymphocytic choriomeningitis virus (LCMV) but not in uninfected controls. This process was also dependent upon the presence of NK cells as depletion of NK cells abrogated the process. These data show that a viral infection in its native host, and not previously implicated in the production of CAV, can contribute to the development of advanced coronary vascular lesions in cardiac allotransplants in mice. These data also suggest that virus-induced CAV can develop via an NK-cell dependent pathway in the absence of T- and B-lymphocytes.

Description

Research Data

Keywords

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Related Stories